Starting a PCD pharma franchise requires more than selecting a product catalogue and placing an opening order. You need a defined business structure, the correct drug-sale permissions, a territory with measurable demand, and a cash-flow plan that survives credit sales and expiry losses. By the end, you will have a practical sequence for validating the opportunity, checking the supplier, signing terms, and beginning compliant sales.
Key takeaways
- Map inventory, selling, storage and payment needs before choosing a franchise structure.
- Confirm required licences, registrations and product permissions before placing an order.
- Calculate territory demand, fixed costs and break-even units before investing.
- Verify the supplier’s documents, batch quality and payment terms in writing.
Choose the Business Structure and Map the Start-to-Finish Route
Choose a PCD pharma franchise if you want to sell an established product range in a defined territory without building a manufacturing plant. It is the wrong structure if you lack working capital for inventory, field selling, storage controls and delayed customer payments.
| Option | Territory control | Customer invoicing | Inventory risk |
|---|---|---|---|
| PCD pharma franchise | Contract-defined territory and channels | Franchise partner or named licence holder | Partner usually carries stock and expiry risk |
| Pharma distributorship | Usually broader, non-exclusive supply area | Distributor invoices pharmacies and institutions | Distributor carries purchasing and credit risk |
| Stockist arrangement | Supplier-led appointment with limited territory rights | Stockist invoices downstream buyers | Stockist holds stock under agreed terms |
| Manufacturing business | Owns production and brand operations | Manufacturer or appointed channel invoices | Manufacturer carries production, compliance and market risk |
Map the route before signing:
- Define the territory, customer types, product categories and expected order frequency; compare doctor density, competing brands, travel time and credit practices.
- Confirm who holds the wholesale sale licence, who invoices customers and who maintains regulatory records. A PCD agreement does not authorize pharmaceutical sale; licence categories depend on the products handled, including Schedules C, C(1) and X.
- Review the agreement for exclusivity, minimum purchases, expiry and damaged-stock handling, approved promotion, complaint escalation and stock ownership after termination.
- Verify the product catalogue’s marketing-authorisation holder, actual manufacturer and release responsibility, then plan batch-level records, temperature logs and an ADR or quality-complaint route.
- Complete the business constitution, PAN, GST registration and required drug-sale licences before placing the first order.
Secure the Licences, Registrations and Product Permissions
A PCD agreement does not authorise you to buy or sell medicines. Before the first invoice, identify the entity holding the drug sale licence, the party issuing invoices, and the party maintaining purchase, batch and complaint records.
Collect and verify these documents:
- PAN, constitution documents, address proof, premises ownership or rent papers, and the responsible pharmacist’s qualification and registration.
- GST registration for a pharmaceutical business, plus a current bank account and authorised-signatory details.
- The applicable wholesale drug licence. Form 20B covers drugs other than those in Schedules C, C(1) and X; Form 21B covers drugs in Schedules C and C(1). Schedule X needs the specific licence category and stricter controls.
- The manufacturer’s licence, GMP evidence under Schedule M, product list, batch release records and certificate of analysis. An ISO certificate alone does not prove statutory manufacturing permission.
Use the agreement to assign responsibility clearly:
| Option | Check before signing | Risk if unclear |
|---|---|---|
| Wholesale franchise | Licence holder and invoice issuer | Unlicensed sales or disputed liability |
| Contract manufacturing | Actual manufacturer and loan-licence details | Missing manufacturing records |
| Brand or marketing owner | Marketing authorisation and complaint owner | You cannot identify the responsible party |
Check every strength and fixed-dose combination. Approval of separate ingredients does not automatically approve the combination; new-drug permission under the New Drugs and Clinical Trials Rules, 2019 may be required.
Separate medicines from FSSAI-regulated supplements. Confirm ingredient, label and claims compliance, and never promote a supplement as treating, curing or preventing disease. Schedule H, H1 and X products require prescription warnings; Schedule H1 supply also needs prescriber, patient and drug records retained for three years.
Test Territory Demand and Calculate the Break-Even Point
Treat a PCD pharma franchise territory as a sales hypothesis, not a guaranteed market. Visit the area and record doctor clinic density, specialties, patient flow, competing brands, stockist coverage, hospital tenders and average travel time between accounts.
- Count target prescribers by therapeutic area and ask retailers which brands move each week.
- Identify three months of likely orders from clinics, pharmacies, hospitals and distributors; separate confirmed interest from polite promises.
- Record competitors’ prices, pack sizes, retailer margins, credit periods and stock availability.
- Estimate how many visits, samples and follow-ups you can complete each month.
- Exclude sales that depend on unauthorised substitution, retailer pressure or unrestricted promotion of Schedule H, H1 or X medicines.
Use these findings in a break-even analysis. Calculate contribution per pack by subtracting product cost, freight, discounts, sales commission, promotional expense and an expiry or damage allowance from the net selling price. Divide monthly fixed costs—salary, travel, storage, licence administration and communication—by that contribution to find required packs.
Then add the cash-flow test: include the opening inventory payment, customer credit period and supplier payment deadline. A territory can show pharma business profitability on paper yet drain cash if retailers pay after 60 days while replenishment is due in 15.
Proceed only if conservative monthly demand exceeds break-even volume and leaves cash to reorder. For prescription-led products, confirm that the local doctor base can generate repeat prescriptions; retailer push alone is not a dependable forecast.
Verify the Supplier and Negotiate Terms Before Paying
Do not transfer an advance until the supplier passes pharma company verification and the written terms match the products you will actually sell. A polished catalogue, ISO certificate or certificate of analysis does not prove that the manufacturing site holds the required legal approvals.
1. Ask for the manufacturer’s statutory manufacturing licence, GMP evidence and site details. Check that the licence covers the dosage forms and strengths offered, and that Schedule M systems cover premises, sanitation, equipment, validation, production, quality control and records. Identify the marketing authorisation holder, actual manufacturer, contract or loan-licence holder, and batch-release party.
2. Check every product individually. Confirm its composition, strength, storage temperature, expiry period, batch traceability and regulatory status. A fixed-dose combination is not automatically lawful because its ingredients are approved separately; confirm permission under the New Drugs and Clinical Trials Rules, 2019 where required.
3. Treat injectables as a separate risk decision. The agreement must name responsibility for sterility or endotoxin failures, particulate contamination, storage excursions, batch release, complaints and recalls. A generic return clause will not protect you.
4. Put territory, channels, invoicing, sale-licence ownership, minimum purchases, payment terms, expiry and damaged-stock handling in the PCD franchise agreement. A promise of monopoly rights has value only when it defines parallel sales, promotional approval, price compliance and stock ownership after termination.
Before committing, compare the documents and service records of suppliers such as kelps healthcare against those terms, rather than choosing on catalogue size alone. Keep signed copies and verify every licence number with the issuing authority.
Place the First Order and Build a Compliant Sales Operation
Place the first order against a written sales forecast, not a supplier’s minimum-order target. Separate fast-moving products from slow-moving lines, set expiry limits, and record purchase order, invoice, batch, quantity and expiry date in your pharma inventory management system.
1. Confirm the order before payment. Match every product with its approved label, strength, dosage form, pack size and storage condition. For injectables, the agreement must assign responsibility for batch release, sterility or endotoxin failures, storage excursions, complaints and pharmaceutical product recall; a general return clause is not enough.
2. Receive stock into a clean, access-controlled area. Record the batch number, expiry date, quantity, dispatch date and temperature evidence, then quarantine damaged, short-dated or temperature-exposed goods until the supplier gives written instructions. Store each product according to its label and stability data; not every injectable requires refrigeration.
3. Sell only through documented channels. Keep invoices linked to the batch and recipient, and apply prescription controls to Schedule H, H1 and X medicines. For Schedule H1 supplies, retain the prescriber, patient and drug details for three years; retailer push cannot replace these records.
4. Build batch traceability from your warehouse to every customer. A spreadsheet or software register must show receipts, transfers, sales and remaining stock, so you can locate and withdraw one affected batch without recalling everything.
5. Create one complaint route. Capture the product name, batch, expiry, patient event, reporter and contact details, then escalate adverse drug reactions through the manufacturer or marketing-authorisation holder for pharmacovigilance review. Document investigation, communication, effectiveness checks and closure.
Frequently asked questions
What should you map before starting a PCD pharma franchise?
Map the route from business structure and licensing through territory research, supplier verification, first order placement and compliant sales operations.
Which licences and permissions are needed for a PCD pharma franchise?
Secure the licences, registrations and product permissions required to stock and sell prescription medicines in your territory before trading.
How do you test demand and calculate break-even for a PCD franchise?
Assess local prescriber, distributor and pharmacy demand, then compare expected gross margin with inventory, selling, storage and payment-related costs.
What should you verify before paying a pharmaceutical supplier?
Check the supplier’s licences, product permissions, manufacturing and batch documents, territory terms, minimum order, payment schedule and return conditions.
